This network includes immunomodulatory factors (IL-10, TGF-β, IDO-1) (15–20), metabolic remodeling of the tumor microenvironment via the arginine pathway (21), and expression of suppressive molecules such as PD-L1 (22). This evidence concerns the gene CD274 and neoplasm.